- Home
- XTLB vs WKSP Comparison
XTLB vs WKSP Comparison
Compare XTLB & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- WKSP
- Stock Information
- Founded
- XTLB 1993
- WKSP 2003
- Country
- XTLB Israel
- WKSP United States
- Employees
- XTLB N/A
- WKSP N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- XTLB Health Care
- WKSP Consumer Discretionary
- Exchange
- XTLB Nasdaq
- WKSP Nasdaq
- Market Cap
- XTLB 12.8M
- WKSP 15.3M
- IPO Year
- XTLB 2005
- WKSP N/A
- Fundamental
- Price
- XTLB $2.20
- WKSP $0.54
- Analyst Decision
- XTLB
- WKSP
- Analyst Count
- XTLB 0
- WKSP 0
- Target Price
- XTLB N/A
- WKSP N/A
- AVG Volume (30 Days)
- XTLB 6.0K
- WKSP 428.8K
- Earning Date
- XTLB 11-20-2024
- WKSP 11-12-2024
- Dividend Yield
- XTLB N/A
- WKSP N/A
- EPS Growth
- XTLB N/A
- WKSP N/A
- EPS
- XTLB N/A
- WKSP N/A
- Revenue
- XTLB N/A
- WKSP $3,732,032.00
- Revenue This Year
- XTLB N/A
- WKSP $386.78
- Revenue Next Year
- XTLB N/A
- WKSP $294.52
- P/E Ratio
- XTLB N/A
- WKSP N/A
- Revenue Growth
- XTLB N/A
- WKSP 1190.52
- 52 Week Low
- XTLB $0.75
- WKSP $0.36
- 52 Week High
- XTLB $4.99
- WKSP $1.97
- Technical
- Relative Strength Index (RSI)
- XTLB 34.54
- WKSP 55.46
- Support Level
- XTLB $2.13
- WKSP $0.48
- Resistance Level
- XTLB $2.31
- WKSP $0.60
- Average True Range (ATR)
- XTLB 0.09
- WKSP 0.05
- MACD
- XTLB -0.02
- WKSP 0.02
- Stochastic Oscillator
- XTLB 15.22
- WKSP 67.22
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers.